Control of myocardial oxygen consumption: physiologic and clinical considerations.
D000255:Adenosine Triphosphate / Q000378:metabolism; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000787:Angina Pectoris / Q000378:metabolism / Q000503:physiopathology; D000818:Animals; D001794:Blood Pressure; D002118:Calcium / Q000494:pharmacology; D002297:Cardanolides / Q000494:pharmacology; D002302:Cardiac Output; D002346:Carotid Sinus / Q000502:physiology; D002395:Catecholamines / Q000494:pharmacology; D002415:Cats; D004071:Digitalis Glycosides / Q000494:pharmacology; D004285:Dogs; D004558:Electric Stimulation; D006321:Heart / Q000502:physiology; D006329:Heart Conduction System / Q000503:physiopathology; D006333:Heart Failure / Q000378:metabolism / Q000503:physiopathology; D006339:Heart Rate; D006349:Heart Valve Diseases / Q000378:metabolism; D006355:Heart-Lung Machine; D006801:Humans; D009119:Muscle Contraction; D009203:Myocardial Infarction / Q000378:metabolism; D009206:Myocardium / Q000378:metabolism*; D009638:Norepinephrine / Q000494:pharmacology; D010101:Oxygen Consumption / Q000187:drug effects; D010210:Papillary Muscles / Q000378:metabolism; D010710:Phosphates / Q000378:metabolism; D011433:Propranolol / Q000494:pharmacology
D000319:Adrenergic beta-Antagonists; D002297:Cardanolides; D002395:Catecholamines; D004071:Digitalis Glycosides; D010710:Phosphates; D000255:Adenosine Triphosphate; D011433:Propranolol; D002118:Calcium; D009638:Norepinephrine